BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26782054)

  • 1. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.
    Amram N; Hacohen-Kleiman G; Sragovich S; Malishkevich A; Katz J; Touloumi O; Lagoudaki R; Grigoriadis NC; Giladi E; Yeheskel A; Pasmanik-Chor M; Jouroukhin Y; Gozes I
    Mol Psychiatry; 2016 Oct; 21(10):1467-76. PubMed ID: 26782054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy.
    Ivashko-Pachima Y; Gozes I
    Prog Mol Biol Transl Sci; 2021; 177():65-90. PubMed ID: 33453943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins.
    Oz S; Kapitansky O; Ivashco-Pachima Y; Malishkevich A; Giladi E; Skalka N; Rosin-Arbesfeld R; Mittelman L; Segev O; Hirsch JA; Gozes I
    Mol Psychiatry; 2014 Oct; 19(10):1115-24. PubMed ID: 25178163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer's pathologies.
    Malishkevich A; Amram N; Hacohen-Kleiman G; Magen I; Giladi E; Gozes I
    Transl Psychiatry; 2015 Feb; 5(2):e501. PubMed ID: 25646590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children.
    Gozes I; Van Dijck A; Hacohen-Kleiman G; Grigg I; Karmon G; Giladi E; Eger M; Gabet Y; Pasmanik-Chor M; Cappuyns E; Elpeleg O; Kooy RF; Bedrosian-Sermone S
    Transl Psychiatry; 2017 Feb; 7(2):e1043. PubMed ID: 28221363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
    Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
    J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New horizons in schizophrenia treatment: autophagy protection is coupled with behavioral improvements in a mouse model of schizophrenia.
    Merenlender-Wagner A; Shemer Z; Touloumi O; Lagoudaki R; Giladi E; Andrieux A; Grigoriadis NC; Gozes I
    Autophagy; 2014; 10(12):2324-32. PubMed ID: 25484074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual divergence in activity-dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease.
    Gozes I
    J Neurosci Res; 2017 Jan; 95(1-2):652-660. PubMed ID: 27870441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy.
    Ivashko-Pachima Y; Sayas CL; Malishkevich A; Gozes I
    Mol Psychiatry; 2017 Sep; 22(9):1335-1344. PubMed ID: 28115743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome.
    Hacohen-Kleiman G; Sragovich S; Karmon G; Gao AYL; Grigg I; Pasmanik-Chor M; Le A; Korenková V; McKinney RA; Gozes I
    J Clin Invest; 2018 Nov; 128(11):4956-4969. PubMed ID: 30106381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH3- and actin-binding domains connect ADNP and SHANK3, revealing a fundamental shared mechanism underlying autism.
    Ivashko-Pachima Y; Ganaiem M; Ben-Horin-Hazak I; Lobyntseva A; Bellaiche N; Fischer I; Levy G; Sragovich S; Karmon G; Giladi E; Shazman S; Barak B; Gozes I
    Mol Psychiatry; 2022 Aug; 27(8):3316-3327. PubMed ID: 35538192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tauopathy in the young autistic brain: novel biomarker and therapeutic target.
    Grigg I; Ivashko-Pachima Y; Hait TA; Korenková V; Touloumi O; Lagoudaki R; Van Dijck A; Marusic Z; Anicic M; Vukovic J; Kooy RF; Grigoriadis N; Gozes I
    Transl Psychiatry; 2020 Jul; 10(1):228. PubMed ID: 32661233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell analysis of cytoskeleton dynamics: From isoelectric focusing to live cell imaging and RNA-seq.
    Gozes I; Ivashko-Pachima Y; Kapitansky O; Sayas CL; Iram T
    J Neurosci Methods; 2019 Jul; 323():119-124. PubMed ID: 31150696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse.
    Sragovich S; Malishkevich A; Piontkewitz Y; Giladi E; Touloumi O; Lagoudaki R; Grigoriadis N; Gozes I
    Transl Psychiatry; 2019 Jan; 9(1):2. PubMed ID: 30664622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADNP Plays a Key Role in Autophagy: From Autism to Schizophrenia and Alzheimer's Disease.
    Sragovich S; Merenlender-Wagner A; Gozes I
    Bioessays; 2017 Nov; 39(11):. PubMed ID: 28940660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Microtubule-Tau Association Enhancer and Neuroprotective Drug Candidate: Ac-SKIP.
    Ivashko-Pachima Y; Gozes I
    Front Cell Neurosci; 2019; 13():435. PubMed ID: 31632241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity-dependent neuroprotective protein (ADNP) expression level is correlated with the expression of the sister protein ADNP2: deregulation in schizophrenia.
    Dresner E; Agam G; Gozes I
    Eur Neuropsychopharmacol; 2011 May; 21(5):355-61. PubMed ID: 20598862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-dependent neuroprotective protein (ADNP) is an alcohol-responsive gene and negative regulator of alcohol consumption in female mice.
    Ziv Y; Rahamim N; Lezmy N; Even-Chen O; Shaham O; Malishkevich A; Giladi E; Elkon R; Gozes I; Barak S
    Neuropsychopharmacology; 2019 Jan; 44(2):415-424. PubMed ID: 30008470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies.
    Karmon G; Sragovich S; Hacohen-Kleiman G; Ben-Horin-Hazak I; Kasparek P; Schuster B; Sedlacek R; Pasmanik-Chor M; Theotokis P; Touloumi O; Zoidou S; Huang L; Wu PY; Shi R; Kapitansky O; Lobyntseva A; Giladi E; Shapira G; Shomron N; Bereswill S; Heimesaat MM; Grigoriadis N; McKinney RA; Rubinstein M; Gozes I
    Biol Psychiatry; 2022 Jul; 92(1):81-95. PubMed ID: 34865853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cytoskeleton as a drug target for neuroprotection: the case of the autism- mutated ADNP.
    Gozes I
    Biol Chem; 2016 Mar; 397(3):177-84. PubMed ID: 25955282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.